This study aimed to assess the effect of co-supplementing rumen-protected fat and rumen-protected choline on growth performance, carcass traits, and meat quality in lambs. Using a randomized experimental design, 45 weaned female Tian×Hu crossbred lambs (3 months old; average body weight: 27.34 ± 0.57 kg, mean ± SD) were randomly allocated to one of three dietary treatment groups. The three dietary treatments were as follows: a basal diet group (CON), a group receiving 2% rumen-protected fat in place of 2% barley (RPF), and a group supplemented with 2% rumen-protected fat and 0.4% rumen-protected choline, replacing 2% barley and 0.4% corn germ in the basal diet (RPFC). Compared to the CON group, neither the RPF nor RPFC treatments resulted in significant differences in growth performance (p > 0.05). However, the RPFC group showed a 5.3% increase in dry matter intake (DMI) compared to the RPF group (p < 0.05). Compared with the CON, the RPF treatment increased 69.23% the relative abundance of C18:2n-6t (p < 0.05), but the content of C17:0, C17:1, C18:1n-9c, and iso-C18:0 in Longissimus lumborum was decreased by 16.49%, 15.78%, 6.45% and 27.78%, respectively (p < 0.05). The RPFC treatment increased the relative abundance of C16:1 in Longissimus lumborum (p < 0.05). The RPF and RPFC treatments significantly increased serum levels of high-density lipoprotein (HDL) and total cholesterol compared to the CON group (p < 0.05). The RPF treatment raised HDL by 50.00% and total cholesterol by 38.03%, while the RPFC treatment increased HDL by 39.47% and total cholesterol by 26.03%. Furthermore, compared to the RPF group, the RPFC treatment led to a 13.47% increase in the 45 min b* color value of the Longissimus lumborum (p < 0.01) and a significant 45.45% reduction in the relative abundance of C18:2n-6t fatty acid in the same muscle (p < 0.05). In summary, rumen-protected choline reduces the negative effects of rumen-protected fat on feed intake in lambs and changes fatty acid profile in meat.
Plectasin, a novel antimicrobial peptide, has the potential to disrupt bacterial cell walls and alter the rumen fermentation mode, making it a superior alternative to antibiotics. However, there is limited research on the effects of plectasin on rumen microbiota. This study aimed to evaluate the effects of plectasin (0.057 μmol/L) on in vitro rumen fermentation characteristics and select groups of rumen bacterial communities in comparison with monensin (5 μmol/L), one of the most commonly used ionophores in ruminants, and as a control treatment with the basal substrate. Unlike monensin, plectasin was found to increase the molar proportions of butyrate and acetate/propionate ratio (p < 0.001) while decreasing pH and the molar proportions of propionate (p < 0.05). Principal component analysis of bacterial 16S rRNA gene amplicons clearly showed a separation between the bacteria shaped by plectasin and monensin. Comparative analysis also revealed differences in the relative abundance of certain bacteria in different taxa between plectasin and monensin. The divergent effects of plectasin and monensin on bacterial communities are likely responsible for the differences in their ability to alter rumen fermentation. Plectasin may have advantages over monensin in modulating ruminal bacterial communities and increasing the butyrate and the acetate/propionate ratio. Therefore, it may be considered as a potential additive for ruminant feed.
Objective: Cysteamine (CS) is known for its ability to regulate hormone secretion. Although widely used as a growth promoter for ruminants, long-term administration at high doses results in intestinal ulceration and growth retardation. We have previously demonstrated that long-term supplementing 20 mg CS/kg body weight (BW) does not affect growth performance.Methods: This study aimed to elucidate the impacts of 30 mg CS kg-1 BW administered for 30 days on growth performance, hormonal profiles, rumen fermentation parameters, rumen bacterial communities, and muscle characteristics in Hu lambs. This dosage and duration regimen was effective in promoting growth performance while avoiding the ruminal negative effects observed at higher doses. Thirty-six male Hu lambs were randomly assigned to two groups.Results: The CS supplementation exhibited increased final BW, average daily gain, and dry matter intake during the first 21 days of the experimental period (p<0.05). Hormonal analysis revealed that CS supplementation increased the levels of growth hormone, luteinizing hormone in the pituitary, testosterone (T) in the testis, and insulin-like growth factor I in the serumwhile decreasing the levels of somatostatin in the hypothalamus and serum (p<0.05). Rumen fermentation analysis indicated an increase in total volatile fatty acids and the proportion of valerate (p<0.05), while the proportion of acetate and the acetate/propionate ratio decreased (p<0.05). Muscle analysis revealed decreased mRNA expression levels of MyHCIIb (p<0.05) in the longissimus dorsi muscle. Western blot analysis showed increased expression of mTOR proteins, along with an elevated phosphorylation level of mTOR (p<0.05) in the longissimus dorsi muscle.Conclusion: Collectively, this study demonstrates that dietary CS supplementation enhances growth performance in Hu lambs by improving rumen function and modulating somatotropic axis hormones.